title: Protective effects of saponin on a hypertension target organ in spontaneously hypertensive rats.
abstract: The present study was undertaken to investigate the protective effects of saponin on a hypertensive target organ (the kidney) in spontaneously hypertensive rats (SHRs) and also to explore the effect of saponin on the renin-angiotensin-aldosterone system (RAAS). A total of 24, 14-week-old SHRs were randomly divided into three groups; the first was administered low-dose saponin, the second with high-dose saponin and the third with a placebo as the control group. An additional eight healthy male Wistar rats were used as the normal group. The blood pressures (BPs) of the rats were determined using an animal BP-6 non-invasive blood pressure tester. Furthermore, the gene expression of TGFB1, collagen I and prorenin receptor (PRR) was determined by quantitative real time (qRT)-PCR. The histopathological and morphological features of the tissue samples were assessed semi-quantitatively. The content of saponin in the renal samples was lower in SHRs than in the normal healthy rats, but the plasma levels of saponin were similar. Mean arterial pressure (MAP) was reduced 5 days subsequent to saponin treatment by 36±3 and 51±4 mmHg in the low- and high-dose saponin groups, respectively. The anti-hypertensive effect of saponin was dose-related during the first 4 weeks of treatment. The gene expression of TGFB1 and collagen I in the renal samples was significantly suppressed in the low- and high-dose saponin groups compared with that in the control group. The gene expression of PRR was significantly and dose-dependently increased in the saponin-treated groups. These findings suggested that saponin reduced systemic BP and blocked the circulating and tissue RAAS.
authors: Department of Pharmacology, Integrative Medicine Clinical College, Anhui University of Traditional Chinese Medicine; Hefei, Anhui 230032; ; Department of Pharmacology, Basic Medical College, Anhui Medical University, Hefei, Anhui 230032;
authors: Ming
authors: M
authors: Chen
authors: Zijiang
authors: Z
authors: Long
authors: Yajuan
authors: Y
authors: Wang
authors: Jinlin
authors: J
authors: Liu
authors: Hai
authors: H
authors: Pian
authors: Liang
authors: L
authors: Wang
authors: Zhiwu
authors: Z
authors: Chen
keywords: hypertension; renin-angiotensin-aldosterone system; saponin
references: J Clin Invest. 2002 Jun;109(11):1417-27
references: 12045255
references: Neurosci Biobehav Rev. 2000 Jan;24(1):31-9
references: 10654658
references: Circulation. 1997 Dec 2;96(11):4065-82
references: 9403633
references: Minerva Cardioangiol. 2003 Apr;51(2):155-64
references: 12783071
references: Circulation. 1999 Sep 7;100(10):1056-64
references: 10477530
references: Hypertension. 2006 Mar;47(3):552-6
references: 16401765
references: Circulation. 2002 Aug 27;106(9):1055-7
references: 12196328
references: Toxicol Appl Pharmacol. 2000 May 1;164(3):250-63
references: 10799335
references: Kidney Int. 2004 Jun;65(6):2309-20
references: 15149345
references: J Clin Invest. 2004 Oct;114(8):1128-35
references: 15489960
references: Blood Press Suppl. 1996;2:22-8
references: 8913536
references: Hypertension. 1998 Jan;31(1 Pt 2):181-8
references: 9453300
references: Circulation. 2000 Nov 28;102(22):2700-6
references: 11094035
references: J Am Soc Nephrol. 2006 Jul;17(7):1950-61
references: 16738017
references: Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H939-48
references: 17483239
references: Circ Res. 1990 Jul;67(1):23-34
references: 2364493
references: J Mol Cell Cardiol. 2002 Dec;34(12):1577-84
references: 12505056